AG
Algert Global Portfolio holdings
AUM
$4.77B
1-Year Return
26.99%
This Quarter Return
+5.53%
1 Year Return
+26.99%
3 Year Return
+120.65%
5 Year Return
+271.18%
10 Year Return
+1,083.42%
AUM
$4.25B
AUM Growth
+$531M
(+14%)
Cap. Flow
+$502M
Cap. Flow
% of AUM
11.82%
Top 10 Holdings %
Top 10 Hldgs %
5.59%
Holding
1,380
New
228
Increased
589
Reduced
316
Closed
227
Top Buys
| 1 |
Chord Energy
CHRD
|
$14.5M |
| 2 |
Mueller Industries
MLI
|
$13.1M |
| 3 |
Banc of California
BANC
|
$12.9M |
| 4 |
Ingredion
INGR
|
$12.7M |
| 5 |
Plains GP Holdings
PAGP
|
$12.6M |
Top Sells
| 1 |
UGI
UGI
|
$13.1M |
| 2 |
Carvana
CVNA
|
$11.2M |
| 3 |
Flex
FLEX
|
$9.87M |
| 4 |
Louisiana-Pacific
LPX
|
$9.64M |
| 5 |
Jefferies Financial Group
JEF
|
$9.02M |
Sector Composition
| 1 | Technology | 16.86% |
| 2 | Financials | 15.67% |
| 3 | Industrials | 15.59% |
| 4 | Healthcare | 12.97% |
| 5 | Consumer Discretionary | 12.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1126
KalVista Pharmaceuticals
KALV
$796M
| $88K | ﹤0.01% |
+10,360
| New | +$88K |
|
1127
Solid Biosciences
SLDB
$428M
| $88K | ﹤0.01% |
22,089
+6,930
| +46% | +$27.6K |
|
1128
Hudbay
HBM
$5.03B
| $86K | ﹤0.01% |
+10,551
| New | +$86K |
|
1129
Mersana Therapeutics
MRSN
$34M
| $86K | ﹤0.01% |
2,403
-136
| -5% | -$4.87K |
|
1130
Alector
ALEC
$305M
| $84K | ﹤0.01% |
44,460
-17,452
| -28% | -$33K |
|
1131
Magnachip Semiconductor
MX
$107M
| $82K | ﹤0.01% |
20,355
| – | – |
|
1132
Teekay
TK
$718M
| $78K | ﹤0.01% |
+11,320
| New | +$78K |
|
|
GPMT
1133
Granite Point Mortgage Trust
GPMT
$143M
| $75K | ﹤0.01% |
26,751
| – | – |
|
1134
RAPT Therapeutics
RAPT
$214M
| $75K | ﹤0.01% |
5,935
| – | – |
|
1135
Pangaea Logistics
PANL
$349M
| $74K | ﹤0.01% |
13,823
| – | – |
|
1136
Future Fuel
FF
$173M
| $73K | ﹤0.01% |
13,880
-2,560
| -16% | -$13.5K |
|
1137
Organogenesis Holdings
ORGO
$634M
| $69K | ﹤0.01% |
+21,447
| New | +$69K |
|
|
BHR
1138
Braemar Hotels & Resorts
BHR
$203M
| $62K | ﹤0.01% |
20,716
| – | – |
|
1139
Trevi Therapeutics
TRVI
$854M
| $61K | ﹤0.01% |
14,779
-9,810
| -40% | -$40.5K |
|
1140
Accuray
ARAY
$170M
| $59K | ﹤0.01% |
29,760
| – | – |
|
1141
Ventyx Biosciences
VTYX
$180M
| $58K | ﹤0.01% |
26,490
| – | – |
|
1142
Entravision Communication
EVC
$226M
| $57K | ﹤0.01% |
24,342
-23,710
| -49% | -$55.5K |
|
|
NGD
1143
New Gold Inc
NGD
$4.99B
| $56K | ﹤0.01% |
22,448
| – | – |
|
1144
Holley
HLLY
$469M
| $53K | ﹤0.01% |
17,560
-101,687
| -85% | -$307K |
|
1145
iHeartMedia
IHRT
$315M
| $50K | ﹤0.01% |
+25,470
| New | +$50K |
|
1146
Larimar Therapeutics
LRMR
$337M
| $47K | ﹤0.01% |
+12,190
| New | +$47K |
|
1147
CytomX Therapeutics
CTMX
$376M
| $35K | ﹤0.01% |
+33,570
| New | +$35K |
|
1148
Compass Therapeutics
CMPX
$590M
| $33K | ﹤0.01% |
22,588
| – | – |
|
1149
Baytex Energy
BTE
$1.67B
| $32K | ﹤0.01% |
12,568
-17,789
| -59% | -$45.3K |
|
1150
PLAYSTUDIOS Inc
MYPS
$122M
| $21K | ﹤0.01% |
11,383
| – | – |
|